Почетна › Кронова болест › Florida › Orlando
Kliničke studije za Кронова болест u gradu Orlando, FL
19 studija za Кронова болест traži učesnike na lokacijama u gradu Orlando i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of SL-325 in Crohn's Disease Patients
Тражи се учесникФаза 2
- Clinical Trial Site, Orlando
- Clinical Trial Site, Kissimmee · 16 ми удаљено
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Тражи се учесникФаза 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Тражи се учесникФаза 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 ми удаљено
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Endoscopic Research Inc, Orlando
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Orlando Health Digestive Health Institute, Orlando
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Тражи се учесникФаза 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · 16 ми удаљено
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Тражи се учесникФаза 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 16 ми удаљено
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Тражи се учесникФаза 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 16 ми удаљено
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Тражи се учесникФаза 4
- Digestive & Liver Center of Florida, Orlando
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 ми удаљено
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 ми удаљено
- и још 1
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Тражи се учесникФаза 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · 24 ми удаљено
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Тражи се учесник
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Тражи се учесникОпсервациона студија
- AdventHealth, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Тражи се учесникФаза 2
- Orlando Health, Inc., Orlando
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Тражи се учесникФаза 2
- Mirador Therapeutics Selected Site, Orlando
Studije za Кронова болест u drugim gradovima
- New York City, NY33 студија
- St. Louis, MO19 студија
- Miami, FL19 студија
- Boston, MA18 студија
- Houston, TX17 студија
- Atlanta, GA16 студија
- Tyler, TX16 студија
- San Diego, CA15 студија
- Cleveland, OH15 студија
- Colorado Springs, CO14 студија
- San Antonio, TX14 студија
- Los Angeles, CA13 студија
Ostale studije u gradu Orlando
- Немалоклетни карцином плућа47 студија
- Гојазност33 студија
- Алцхајмерова болест29 студија
- Метастатски карцином28 студија
- Гојазност27 студија
- Dijabetes tipa 225 студија
- Рак јајника24 студија
- Рак (све врсте)24 студија
- Рак дојке23 студија
- Рак плућа23 студија
- Ulcerativni kolitis21 студија
- Колоректални карцином21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.